SCHEMBL5950786

SCHEMBL5950786

Nc1ccc(N2CCC[C@H](NC(=O)N3C4CCC3CC(O)C4)C2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 1/20 0.41
NPSR1 Q6W5P4 2/20 0.38
BTK Q06187 2/20 0.37
LCK P06239 1/20 0.37
USP2 O75604 3/20 0.37
POLB P06746 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
JAK3 P52333 1/20 0.37
SMYD3 Q9H7B4 1/20 0.36
MAPT P10636 2/20 0.36
GFER P55789 1/20 0.36
NAMPT P43490 1/20 0.36
HRH3 Q9Y5N1 1/20 0.36
GAA P10253 2/20 0.35
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
NPC1 O15118 1/20 0.35
ALDH1A1 P00352 1/20 0.35
TP53 P04637 1/20 0.35
THRB P10828 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4004043 1.00 CNR1 (0.41) CNR1NPSR1BTKLCKUSP2
SCHEMBL4003351 0.89 POLB (0.49) CNR1NPSR1POLBMAPTKDM4E
SCHEMBL4003357 0.89 POLB (0.49) CNR1NPSR1POLBMAPTKDM4E
SCHEMBL5950313 0.88 CNR1 (0.53) CNR1NPSR1USP2SMN1; SMN2NAMPT
SCHEMBL4151117 0.87 HPGD (0.49) CNR1LCKSMN1; SMN2JAK3MAPT
SCHEMBL4151115 0.87 HPGD (0.49) CNR1LCKSMN1; SMN2JAK3MAPT
SCHEMBL4150094 0.87 CNR1 (0.47) CNR1NPSR1USP2SMN1; SMN2NAMPT
SCHEMBL4011753 0.87 CNR1 (0.47) CNR1NPSR1USP2SMN1; SMN2NAMPT
SCHEMBL4149170 0.86 HPGD (0.46) CNR1LCKSMN1; SMN2JAK3MAPT
SCHEMBL4149172 0.86 HPGD (0.46) CNR1LCKSMN1; SMN2JAK3MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060122197-A1 Amido compounds and their use as pharmaceuticals INCYTE CORPORATION 2006-06-08 US claimed
US-20060122197-A1 Amido compounds and their use as pharmaceuticals INCYTE CORPORATION 2006-06-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060122197-A1 Amido compounds and their use as pharmaceuticals HSD11B1, CYP11B1, HSD11B2 CNR1 516/4885NPSR1 615/4885BTK 2479/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.